Refine Search
(47)
(146)
(339)
(368)

Osteogenesis Imperfecta - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Osteogenesis Imperfecta - Pipeline Review, H1 2019’, provides an overview of the Osteogenesis Imperfecta pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2019’, provides an overview of the Chemotherapy Induced Peripheral Neuropathy pipeline landscape.

The report provides comprehensive information on...

Duchenne Muscular Dystrophy - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Duchenne Muscular Dystrophy - Pipeline Review, H1 2019’, provides an overview of the Duchenne Muscular Dystrophy pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Fabry Disease - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fabry Disease - Pipeline Review, H1 2019’, provides an overview of the Fabry Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Fabry Disease, com...

Familial Adenomatous Polyposis - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Familial Adenomatous Polyposis - Pipeline Review, H1 2019’, provides an overview of the Familial Adenomatous Polyposis pipeline landscape.

The report provides comprehensive information on the therapeutics under ...

Primary Immune Deficiency (PID) - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Primary Immune Deficiency (PID) - Pipeline Review, H1 2019’, provides an overview of the Primary Immune Deficiency (PID) pipeline landscape.

The report provides comprehensive information on the therapeutics unde...

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) – Pipeline Review, H1 2019

  • $3,500
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2019’, provides in depth analysis on Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subuni...

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) – Pipeline Review, H1 2019

  • $3,500
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H1 2019’, provides in depth analysis on Granulocyte Macrophage Colony Stimulating Factor Receptor S...

P2X Purinoceptor 3 (P2RX3) – Pipeline Review, H1 2019

  • $3,500
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘P2X Purinoceptor 3 (P2RX3) - Pipeline Review, H1 2019’, provides in depth analysis on P2X Purinoceptor 3 (P2RX3) targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by...

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) – Pipeline Review, H1 2019

  • $3,500
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H1 2019’, provides in depth analysis on P2X Purinoceptor 7 (P2Z Receptor or P2RX7) targeted pipeline therapeutics. The report provides comprehensive informa...

Becker Muscular Dystrophy - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Becker Muscular Dystrophy - Pipeline Review, H1 2019’, provides an overview of the Becker Muscular Dystrophy pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Crigler-Najjar Syndrome - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Crigler-Najjar Syndrome - Pipeline Review, H1 2019’, provides an overview of the Crigler-Najjar Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) – Pipeline Review, H1 2019

  • $3,500
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Pipeline Review, H1 2019’, provides in depth analysis on Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) targeted pipeline therapeutics. The rep...

Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) – Pipeline Review, H1 2019

  • $3,500
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Pipeline Review, H1 2019’, provides in depth analysis on Sodium And Chloride Dependent Glycine Transporter 1 (...

Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) – Pipeline Review, H1 2019

  • $3,500
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF...